Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
about
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SA Training Model for Implementing Hepatitis Prevention Services in Substance Use Disorder Clinics: A Qualitative Evaluation.Cirrhosis and its complications: evidence based treatment.Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases.Identification of acute vaccine-preventable hepatitis in individuals with chronic hepatitis in British Columbia between 1991 and 2007.Prevention of hepatitis A by vaccination.Review article: hepatitis vaccination in patients with chronic liver disease.Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.Seroprevalence of hepatitis a in patients with chronic hepatitis C in isfahan province.Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States.Safety and efficacy of hepatitis B vaccination in cirrhosis of liver.Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary.Medical Care of the Patient With Compensated Cirrhosis.Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirinKnowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.Vaccinating patients with chronic liver disease.Multiple viral hepatitis in injection drug users and associated risk factors.
P2860
Q27489610-425C70CB-7D44-4F52-86A4-55EE50608F5CQ30658467-7DFF385B-6626-42E1-9EA4-CAD0629BC16FQ33594931-DBCA226B-4904-4D54-A8F1-C0869C3406C0Q34502980-F53C898C-4786-4C48-8B0A-0365376B3711Q34767141-4D2C7183-4307-4E66-AD00-07106E099A51Q34789762-44B73FF7-D8C3-4AD0-87B7-10377167C1B4Q35207528-CAAAE213-1C11-445E-AB6C-AF7A00B0A2C7Q35714136-201DF62D-46E7-40C7-9D04-96F152E3759CQ35737654-5AA951BB-ABD3-4E98-9F63-BDD96C19AC6AQ36101920-175D79A2-C7B3-4256-84F9-2BCB45CB3E24Q36901395-637E68CF-038D-44F1-8060-9B2CB143C7E4Q36948427-AA58F04A-8547-4202-A624-EAFF8F4D77B8Q37300014-AF76C640-AEA2-47EB-8B26-C0A66F845A86Q37678908-6AA530C3-C4DD-4856-B473-8326D096580CQ38679899-766BBA9D-F921-4D36-9521-25FA09A7A30EQ40063920-E5667D25-C359-4553-9048-CE524C28E74DQ42560073-AFA5436C-2128-44FA-9DF2-53A371F963BCQ52290488-3BE87419-3BFA-42DB-A5F6-1C0C74E7AE43
P2860
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@ast
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@en
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@nl
type
label
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@ast
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@en
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@nl
prefLabel
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@ast
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@en
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@nl
P1476
Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
@en
P2093
P356
10.1097/00004836-200107000-00006
P577
2001-07-01T00:00:00Z